Launching a new medical curriculum during "normal" times is complex. Add in an unexpected pandemic and implementation is further complicated. Hear how the University of Miami Miller School of Medicine tackled these challenges in this edition of Inside U Miami Medicine, hosted by Dean Henri Ford and featuring Dr. Gauri Agarwal, associate dean of curriculum, and Dr. Amar Deshpande, associate dean for medical education.

Paving the way for minority students to become physicians is essential for achieving health equity. Dr. Nanette Vega, assistant dean for the Office of Diversity, Inclusion, and Community Engagement at the University of Miami Miller School of Medicine, joins Dean Henri Ford to discuss a pivotal program that positions these students to successfully compete for admission to medical school.

Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School, joins Dean Henri Ford to give insight into this devastating illness and the search for better outcomes.

Alzheimer’s research, from previous studies to ongoing clinical trials, is often not representative of the populations that are at the highest risk for this disease. Margaret Pericak-Vance, Ph.D., sits down with Dean Henri Ford to discuss a multi-center, multi-national clinical trial that will tackle this issue and expand diversity in Alzheimer’s data, eventually leading to the development of targeted drug therapies.